Growth Metrics

Oncology Institute (TOI) Deferred Taxes (2021 - 2023)

Oncology Institute's Deferred Taxes history spans 3 years, with the latest figure at -$126000.0 for Q4 2023.

  • For Q4 2023, Deferred Taxes rose 71.75% year-over-year to -$126000.0; the TTM value through Sep 2024 reached -$126000.0, up 68.18%, while the annual FY2025 figure was -$32000.0, N/A changed from the prior year.
  • Deferred Taxes reached -$126000.0 in Q4 2023 per TOI's latest filing, down from $80000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $2.3 million in Q4 2021 to a low of -$3.8 million in Q3 2021.
  • Average Deferred Taxes over 3 years is -$143727.3, with a median of -$4000.0 recorded in 2023.
  • The largest YoY upside for Deferred Taxes was 101.38% in 2022 against a maximum downside of 119.43% in 2022.
  • A 3-year view of Deferred Taxes shows it stood at $2.3 million in 2021, then crashed by 119.43% to -$446000.0 in 2022, then soared by 71.75% to -$126000.0 in 2023.
  • Per Business Quant, the three most recent readings for TOI's Deferred Taxes are -$126000.0 (Q4 2023), $80000.0 (Q3 2023), and -$4000.0 (Q2 2023).